Individual responses to growth hormone (GH) treatment are variable. Short-term generation of insulin-like growth factor-I (IGF-I) is recognized as a potential marker of sensitivity to GH treatment.

Growth hormone, insulin-like growth factor I and insulin have potent growth-promoting and anabolic actions. Their potential involvement in tumor promotion and progression has been of concern for ...

There are two forms of insulin-like growth factor: IGF-1 and IGF-2. ... A synthetic analogue of IGF1 is used to treat growth failure in children who have abnormal IGF-1 synthesis, ...

blood tests to measure levels of hormones such as insulin-like growth factor and insulin-like growth ... (2020). Craniofacial morphology in children with growth hormone deficiency and ...

Insulin-like growth factor I (IGF-I) circulates predominantly as a 150-kD ternary complex that includes the ligand itself, IGF-binding protein 3, and an acid-labile subunit that stabilizes the comp ...

A once-weekly growth hormone therapy improved growth-related endpoints for adolescents with multiple conditions of short ...

Research has identified a mechanism through which insulin-like growth factors facilitate brain plasticity. The insulin super-family of hormones, including insulin, insulin-like growth factor 1 ...

The recommended dose of SKYTROFA for treatment-naïve children with growth hormone deficiency and ... The dose may be adjusted based on the child's weight and insulin-like growth factor-1 ...

Of particular recent interest is the growth hormone (GH)/insulin-like growth factor-I (IGF-I) system. In the context of skeletal muscle homoeostasis, IGF-I is thought to mediate the majority of the ...

Insulin–insulin-like growth factor (IGF) axis. Insulin is produced by the pancreas and binds insulin, insulin–insulin-like growth factor (IGF), or hybrid insulin/IGF receptors to promote downstream ...